YKL-06-101

YKL-06-101 is a bivalent small molecule that combines mTOR inhibition (IC50=6 nM) and degradation of CDK8 (CDK8/Cyclin C IC50=31 nM).

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock	Quantity	Order
100mg	3885	Inquire

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670


Purity	>98%
Formula	C58H57F3N8O11
Mol Weight	1099.1154
State	solid powder
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Menzl, Ingeborg et al. “A kinase-independent role for CDK8 in BCR-ABL1+ leukemia.” Nature communications vol. 10,1 4741. 18 Oct. 2019
CoA	CoA of YKL-06-101


		Search